T. Castel

发表

CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia

X. Estivill, J. Malvehy, S. Puig, 1999, Journal of medical genetics.

Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.

D. Colomer, B. Mellado, E. Carballo, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serum Protein S-100 Predicts Clinical Outcome in Patients with Melanoma Treated with Adjuvant Interferon – Comparison with Tyrosinase RT-PCR

J. Malvehy, S. Puig, B. Mellado, 2005, Oncology.

Tyrosinase m RNA i n B lood o f P atients W ith M elanoma Treated W ith A djuvant I nterferon

D. Colomer, B. Mellado, N. Reguart, 2002 .

Tyrosinase mRNA in blood of patients with melanoma treated with adjuvant interferon.

D. Colomer, B. Mellado, N. Reguart, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?

S. Puig, J. Palou, A. Vilalta, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene.

X. Estivill, J. Weissenbach, S. Puig, 1995, American journal of human genetics.

Role of the CDKN2A locus in patients with multiple primary melanomas.

J. Malvehy, S. Puig, C. Badenas, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Malignant melanoma with metastasis into the capitate.

C. Nicolau, A. Combalía, T. Castel, 2005, European journal of radiology.

Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.

D. Colomer, B. Mellado, L. Gutierrez, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Immunohistochemical study of alpha, mu and pi class glutathione S transferase expression in malignant melanoma

R. Molina, J. Palou, T. Castel, 1997, The British journal of dermatology.

Retention of the CDKN2A locus and low frequency of point mutations in primary and metastasic cutaneous malignant melanoma

X. Estivill, S. Puig, A. Ruiz, 1998, International journal of cancer.

Clinical outcome after surgical resection of lung metastases from melanoma

J. Malvehy, S. Puig, J. Gimferrer, 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

spondylitis . of patients with ankylosing Immunoglobulin A in the skin

J. Rotés-Querol, J. Cañete, R. Sanmartí, 2004 .

Immunoglobulin A in the skin of patients with ankylosing spondylitis.

J. Rotés-Querol, J. Cañete, R. Sanmartí, 1988, Annals of the rheumatic diseases.

Immunoglobulin A intheskinofpatients with ankylosing spondylitis

J. Rotés-Querol, R. Sanmartí, T. Castel, 1988 .

Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary?

S. Puig, J. Palou, A. Vilalta, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Zidovudine-induced nail pigmentation.

J. Mallolas, T. Castel, J. Gatell, 1988, Archives of dermatology.

Temozolomide as prophylaxis for melanoma brain metastases

J. Malvehy, S. Puig, R. Martí, 2004, Melanoma research.

Gamma-detecting probe used intraoperatively to locate the sentinel lymph node in patients with malignant melanoma.

J. Visa, R. Herranz, R. Rull, 2001, The European journal of surgery = Acta chirurgica.

Toxicity of combined treatment of adjuvant irradiation and interferon &agr;2b in high-risk melanoma patients

J. Malvehy, S. Puig, Marcelo Sánchez, 2007, Melanoma research.

Ultrastructural Findings in Acute and Chronic Graft‐Vs‐Host Reaction of the Skin *

A. Grañena, E. Feliú, C. Rozman, 1980, Journal of cutaneous pathology.

Adjuvant treatment in stage I and II malignant melanoma: a randomized trial between chemoimmunotherapy and immunotherapy.

N. Viñolas, J. Palou, A. Vilalta, 1991, Dermatologica.

Phenotype of glutathione S-transferase Mu (GSTM1) and susceptibility to malignant melanoma. MMM group. Multidisciplinary Malignant Melanoma Group.

R. Molina, J. Palou, T. Castel, 1995, British Journal of Cancer.

Acute and chronic graft‐vs‐host reaction in skin: report of two cases *

A. Grañena, J. Mallolas, E. Feliú, 1980, The British journal of dermatology.

S-100 Protein Serum Levels in Patients with Benign and Malignant Diseases: False-Positive Results Related to Liver and Renal Function

R. Molina, T. Castel, X. Filella, 2002, Tumor Biology.

Prognostic Implications of Protein S-100β Serum Levels in the Clinical Outcome of High-Risk Melanoma Patients

J. Malvehy, S. Puig, B. Mellado, 2007, Tumor Biology.

Specific cutaneous manifestations of Waldenström's macroglobulinaemia. A report of two cases *

E. Montserrat, J. Mallolas, E. Feliú, 1982, The British journal of dermatology.

Bullous pemphigoid induced by Frusemide

M. Lecha, T. Castel, J. Mascaró, 1981, Clinical and experimental dermatology.

[Cicatricial pemphigoid of Brunsting Perry].

M. Lecha, C. Herrero, T. Castel, 1979, Actas dermo-sifiliograficas.

A polysensitized HIV‐positive patient

M. Lecha, J. Vilaplana, C. Romaguera, 1993, Contact dermatitis.

Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene

X. Estivill, J. Malvehy, S. Puig, 1997, Human Genetics.

[Minimal change nephropathy associated with an acquired immune deficiency syndrome].

J. Montoliu, X. Lens, A. Cases, 1986, Medicina clinica.

S-100beta and MIA in advanced melanoma in relation to prognostic factors.

J. Malvehy, S. Puig, R. Molina, 2005, Anticancer research.

Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanoma.

J. Malvehy, S. Puig, R. Molina, 2007, Anticancer research.

Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma

Marcelo Sánchez, T. Castel, S. Massaguer, 2004, European Radiology.

Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-&agr; in patients with metastatic melanoma

J. Malvehy, S. Puig, B. Mellado, 2006, Melanoma research.

Whole brain irradiation and temozolomide based chemotherapy in melanoma brain metastases

J. Malvehy, S. Puig, Marcelo Sánchez, 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patients

J. Malvehy, S. Puig, J. Visa, 2004, Melanoma research.

Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate

J. Malvehy, S. Puig, B. Mellado, 2004, Cancer Immunology, Immunotherapy.

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

J. Malvehy, S. Puig, C. Conill, 2017, Melanoma research.

Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine

J. Malvehy, S. Puig, B. Mellado, 2003, International journal of cancer.

Preoperative assessment of cutaneous melanoma thickness using 10-MHz sonography.

J. Malvehy, S. Puig, Marcelo Sánchez, 2009, AJR. American journal of roentgenology.

Prognostic value of tyrosinase reverse transcriptase PCR analysis in melanoma sentinel lymph nodes: long‐term follow‐up analysis

J. Malvehy, S. Puig, C. Badenas, 2009, Clinical and experimental dermatology.

Mid-arm sentinel lymph nodes showing surprising drainage from a malignant melanoma in the forearm.

J. Palou, R. Herranz, S. Vidal-Sicart, 1998, Clinical nuclear medicine.

Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial

J. Malvehy, S. Puig, B. Mellado, 2005, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines

J. Malvehy, X. Matías-Guiu, J. Comella, 2006, Melanoma research.

[Sentinel lymph node detection with lymphoscintigraphy and intraoperative probe in malignant melanoma patients].

J. Palou, R. Herranz, S. Vidal-Sicart, 1999, Medicina clinica.

Why do melanomas ulcerate?

M. Lecha, T. Castel, J. Mascaró, 1984, Journal of cutaneous pathology.

Reiter's Sydrome Associated With Hypozincemia in an HIV‐Positive Patient

T. Castel, G. Hausmann, P. Iranzo, 1988 .

Atypical schwannoma of the median nerve. A case report.

G. Herzberg, T. Castel, M. Burnier, 2019, Hand surgery & rehabilitation.

[Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. An analysis of 67 cases with a study of the prognostic factors].

J. Miro, J. Gatell, J. Mallolas, 1990, Medicina clinica.